Status:
COMPLETED
Fascia Iliaca Compartment Block Versus Quadratus Lumborum Block in Total Hip Arthroplasty
Lead Sponsor:
Seoul National University Hospital
Conditions:
Nerve Block
Pain, Postoperative
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
Patients undergoing total hip arthroplasty are randomly assigned to two groups (fascia iliaca compartement block \[FICB\] group or quadratus lumborum block \[QLB\] group). In the FICB group, ultrasoun...
Eligibility Criteria
Inclusion
- Adult patients between the ages of 19 and 70 undergoing total hip arthroplasty under spinal anesthesia
- Be able to provide written consent to participate in clinical trials, understand the procedures of this clinical trial, and be able to properly fill out patient-reported questionnaires
- ASA physical status classification 1-2
Exclusion
- ASA physical status classification 3-4
- Patients who are contraindicated to nerve blocks (hypersensitivity to local anesthetics, infection at the injection site, etc.)
- Patients with chronic pain and taking pain medications, antidepressants, and anticonvulsants
- Other major medical or psychiatric conditions that will affect response to treatment
- Refusal of intravenous patient-controlled analgesia
- Patients determined to be unsuitable for this clinical trial by the researchers
Key Trial Info
Start Date :
March 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05228028
Start Date
March 22 2022
End Date
December 22 2022
Last Update
December 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080